Try our beta test site
22 studies found for:    corcept
Show Display Options
Rank Status Study
1 Completed A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
Condition: Depressive Disorder, Major
Intervention: Drug: Mifepristone
2 Completed An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
Conditions: Major Depressive Disorder;   Psychotic Disorders
Intervention: Drug: Mifepristone
3 Recruiting Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
Condition: Cushing's Syndrome
Intervention:
4 Recruiting Study to Evaluate CORT125134 in Patients With Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: CORT125134
5 Recruiting Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors
Conditions: Solid Tumors;   Cellular Diagnosis, Ovarian Epithelial Cancer;   Breast Cancer
Intervention: Drug: CORT125134 with nab-paclitaxel
6 Completed
Has Results
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Conditions: Cushing's Disease;   Cushing's Syndrome
Intervention: Drug: Mifepristone
7 Completed
Has Results
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
8 Terminated A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Condition: Cushing's Syndrome
Intervention: Drug: Cushing's syndrome confirmation
9 Completed
Has Results
A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
Condition: Healthy
Interventions: Drug: risperidone;   Drug: risperidone matched placebo;   Drug: risperidone-matched placebo;   Drug: Mifepristone-matched placebo
10 Terminated
Has Results
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Conditions: Psychotic Depression;   Severe Major Depression With Psychotic Features;   Psychosis
Interventions: Drug: mifepristone;   Drug: placebo
11 Completed
Has Results
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
12 Completed A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain
Condition: Weight-Gain Prevention
Intervention: Drug: Mifepristone
13 Completed An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
Condition: Major Depressive Disorder
Interventions: Drug: Mifepristone;   Drug: placebo
14 Completed A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
Conditions: Major Depressive Disorder;   Psychotic Disorders
Interventions: Drug: Mifepristone;   Drug: matching placebo
15 Completed A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
Conditions: Major Depressive Disorder;   Psychotic Disorders
Interventions: Drug: mifepristone;   Drug: mifepristone matched placebo;   Drug: mifepristone 600 mg;   Drug: mifepristone 1200 mg
16 Completed A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
Condition: Healthy Subjects
Intervention: Drug: mifepristone + fluvastatin
17 Completed A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body
Condition: Healthy
Intervention: Drug: [14C]-CORT125134
18 Enrolling by invitation Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Other: No intervention
19 Active, not recruiting Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Conditions: Breast Cancer;   Ovarian Epithelial Cancer Recurrent;   Sarcoma;   Non-small Cell Lung Cancer;   Carcinoma, Transitional Cell;   Prostate Cancer;   Prostatic Neoplasms
Intervention: Drug: Mifepristone and Eribulin in combination
20 Withdrawn Mifepristone in Children With Refractory Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: mifepristone

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.